Literature DB >> 32295786

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.

Elizabeth R Graef1, Jean W Liew2, Alfred Hj Kim3, Jeffrey A Sparks4, Michael S Putman5, Julia F Simard6,7, Emily Sirotich8, Francis Berenbaum9, Alí Duarte-García10, Rebecca Grainger11, Carly Harrison12, Maximilian F Konig13, Peter Korsten14, Laurie Proulx15, Dawn P Richards15, Philip C Robinson16, Sebastian E Sattui17, Manuel Francisco Ugarte-Gil18, Kristen J Young19.   

Abstract

Entities:  

Keywords:  antirheumatic agents; health services research; hydroxychloroquine

Mesh：

Substances：

Year:  2020        PMID： 32295786      PMCID： PMC7359879          DOI： 10.1136/annrheumdis-2020-217480

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  12 in total

1.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

2.  Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.

Authors:  Victor R Pimentel-Quiroz; Manuel F Ugarte-Gil; Guillermo J Pons-Estel; Enrique R Soriano; Verónica Saurit; Emilia I Sato; Lilian T Lavras Costallat; José Fernando Molina; Antonio Iglesias-Gamarra; Gil Reyes-Llerena; Oscar J Neira; Leonor A Barile; Luis H Silveira; María Ines Segami; Rosa Chacón-Díaz; Daniel Wojdyla; Graciela S Alarcón; Bernardo A Pons-Estel
Journal:  Semin Arthritis Rheum       Date:  2017-02-02       Impact factor: 5.532

3.  A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

Authors: 
Journal:  N Engl J Med       Date:  1991-01-17       Impact factor: 91.245

Review 4.  Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Claire Rempenault; Bernard Combe; Thomas Barnetche; Cécile Gaujoux-Viala; Cédric Lukas; Jacques Morel; Charlotte Hua
Journal:  Ann Rheum Dis       Date:  2017-09-25       Impact factor: 19.103

5.  Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Authors:  Ian N Bruce; Aidan G O'Keeffe; Vern Farewell; John G Hanly; Susan Manzi; Li Su; Dafna D Gladman; Sang-Cheol Bae; Jorge Sanchez-Guerrero; Juanita Romero-Diaz; Caroline Gordon; Daniel J Wallace; Ann E Clarke; Sasha Bernatsky; Ellen M Ginzler; David A Isenberg; Anisur Rahman; Joan T Merrill; Graciela S Alarcón; Barri J Fessler; Paul R Fortin; Michelle Petri; Kristjan Steinsson; Mary Anne Dooley; Munther A Khamashta; Rosalind Ramsey-Goldman; Asad A Zoma; Gunnar K Sturfelt; Ola Nived; Cynthia Aranow; Meggan Mackay; Manuel Ramos-Casals; Ronald F van Vollenhoven; Kenneth C Kalunian; Guillermo Ruiz-Irastorza; Sam Lim; Diane L Kamen; Christine A Peschken; Murat Inanc; Murray B Urowitz
Journal:  Ann Rheum Dis       Date:  2014-05-16       Impact factor: 19.103

6.  Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015.

Authors:  Moon-Woo Seong; So Yeon Kim; Victor Max Corman; Taek Soo Kim; Sung Im Cho; Man Jin Kim; Seung Jun Lee; Jee-Soo Lee; Soo Hyun Seo; Ji Soo Ahn; Byeong Su Yu; Nare Park; Myoung-don Oh; Wan Beom Park; Ji Yeon Lee; Gayeon Kim; Joon Sung Joh; Ina Jeong; Eui Chong Kim; Christian Drosten; Sung Sup Park
Journal:  Emerg Infect Dis       Date:  2016-02       Impact factor: 6.883

7.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

8.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).

Authors:  Tao Guo; Yongzhen Fan; Ming Chen; Xiaoyan Wu; Lin Zhang; Tao He; Hairong Wang; Jing Wan; Xinghuan Wang; Zhibing Lu
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

9.  Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Jacques Sevestre; Morgane Mailhe; Barbara Doudier; Camille Aubry; Sophie Amrane; Piseth Seng; Marie Hocquart; Carole Eldin; Julie Finance; Vera Esteves Vieira; Hervé Tissot Tissot-Dupont; Stéphane Honoré; Andreas Stein; Matthieu Million; Philippe Colson; Bernard La Scola; Véronique Veit; Alexis Jacquier; Jean-Claude Deharo; Michel Drancourt; Pierre Edouard Fournier; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Travel Med Infect Dis       Date:  2020-04-11       Impact factor: 6.211

10.  A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.

Authors:  Alfred H J Kim; Jeffrey A Sparks; Jean W Liew; Michael S Putman; Francis Berenbaum; Alí Duarte-García; Elizabeth R Graef; Peter Korsten; Sebastian E Sattui; Emily Sirotich; Manuel F Ugarte-Gil; Kate Webb; Rebecca Grainger
Journal:  Ann Intern Med       Date:  2020-03-30       Impact factor: 25.391
View more
  12 in total

1.  Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Authors:  Alfred Hyoungju Kim; Jeffrey A Sparks; Ali Duarte-García; Elizabeth R Graef; Jean W Liew; Maximilian F Konig
Journal:  Ann Rheum Dis       Date:  2020-08-07       Impact factor: 19.103

2.  Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.

Authors:  Alfred Hyoungju Kim; Jeffrey A Sparks; Manuel Francisco Ugarte-Gil; Maximilian F Konig; Peter Korsten; Francis Berenbaum
Journal:  Ann Rheum Dis       Date:  2020-08-05       Impact factor: 19.103

3.  Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.

Authors:  C Sieiro Santos; C Moriano Morales; E Díez Álvarez; C Álvarez Castro; A López Robles; T Perez Sandoval
Journal:  Clin Rheumatol       Date:  2020-07-27       Impact factor: 2.980

4.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Authors:  Milena Gianfrancesco; Kimme L Hyrich; Jinoos Yazdany; Pedro M Machado; Philip C Robinson; Sarah Al-Adely; Loreto Carmona; Maria I Danila; Laure Gossec; Zara Izadi; Lindsay Jacobsohn; Patricia Katz; Saskia Lawson-Tovey; Elsa F Mateus; Stephanie Rush; Gabriela Schmajuk; Julia Simard; Anja Strangfeld; Laura Trupin; Katherine D Wysham; Suleman Bhana; Wendy Costello; Rebecca Grainger; Jonathan S Hausmann; Jean W Liew; Emily Sirotich; Paul Sufka; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

5.  The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey.

Authors:  Emire Seyahi; Burc Cagri Poyraz; Necdet Sut; Selma Akdogan; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2020-06-22       Impact factor: 3.580

6.  Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.

Authors:  Kristin M D'Silva; Naomi Serling-Boyd; Rachel Wallwork; Tiffany Hsu; Xiaoqing Fu; Ellen M Gravallese; Hyon K Choi; Jeffrey A Sparks; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2020-05-26       Impact factor: 27.973

Review 7.  COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.

Authors:  Allison P Spihlman; Nirupa Gadi; Samantha C Wu; Vaishali R Moulton
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

8.  The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study.

Authors:  Nelly Ziadé; Ihsane Hmamouchi; Lina El Kibbi; Nizar Abdulateef; Hussein Halabi; Fatemah Abutiban; Wafa Hamdi; Manal El Rakawi; Mervat Eissa; Basel Masri
Journal:  Clin Rheumatol       Date:  2020-09-30       Impact factor: 2.980

9.  COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.

Authors:  Claudia Elera-Fitzcarrald; Manuel F Ugarte-Gil; Graciela S Alarcón
Journal:  J Clin Rheumatol       Date:  2020-09       Impact factor: 3.902

10.  Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Michael Putman; Yu Pei Eugenia Chock; Herman Tam; Alfred H J Kim; Sebastian E Sattui; Francis Berenbaum; Maria I Danila; Peter Korsten; Catalina Sanchez-Alvarez; Jeffrey A Sparks; Laura C Coates; Candace Palmerlee; Andrea Peirce; Arundathi Jayatilleke; Sindhu R Johnson; Adam Kilian; Jean Liew; Larry J Prokop; M Hassan Murad; Rebecca Grainger; Zachary S Wallace; Alí Duarte-García
Journal:  Arthritis Rheumatol       Date:  2020-11-19       Impact factor: 15.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.